(TXN) Texas Instruments - Overview
Stock: Analog, Embedded, Microcontrollers, Power Management, Semiconductors
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.14% |
| Yield on Cost 5y | 3.66% |
| Yield CAGR 5y | 6.91% |
| Payout Consistency | 97.9% |
| Payout Ratio | 81.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 32.5% |
| Relative Tail Risk | -10.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.64 |
| Alpha | 6.63 |
| Character TTM | |
|---|---|
| Beta | 1.305 |
| Beta Downside | 1.519 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.41% |
| CAGR/Max DD | 0.34 |
Description: TXN Texas Instruments January 26, 2026
Texas Instruments (NASDAQ:TXN) designs, manufactures, and sells a broad portfolio of analog and embedded-processing semiconductors to customers worldwide, spanning the United States, China, the rest of Asia, Europe, the Middle East, Africa, and Japan. The Analog segment focuses on power management (e.g., DC/DC converters, linear regulators) and signal-chain components (e.g., amplifiers, data converters), while the Embedded Processing segment supplies microcontrollers, processors, wireless and radar solutions, plus DLP technology for projectors and calculators. Sales are executed through a mix of direct teams, distributors, and the company’s website.
In the most recent quarter (Q2 FY2024), Texas Instruments reported revenue of $3.2 billion, a 9 % year-over-year increase, driven primarily by a 12 % YoY rise in Analog sales and a 5 % gain in Embedded Processing. Operating margin expanded to 34 %, and the firm generated $1.2 billion of free cash flow, supporting a $5 billion share-repurchase program announced earlier in the year. The balance sheet remains strong, with a cash-to-debt ratio of 3.8 ×.
The company’s outlook is closely tied to macro trends: accelerating adoption of AI accelerators and electric-vehicle power-train architectures is boosting demand for high-efficiency analog components; ongoing global fab capacity constraints are pressuring lead times, favoring TI’s vertically integrated model; and the U.S. CHIPS Act incentives are expected to sustain domestic investment in semiconductor manufacturing, partially offsetting trade-related uncertainties with China.
For a deeper, data-driven assessment of TXN’s valuation and risk profile, you may want to explore the analyst tools available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 5.00b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 3.31 > 1.0 |
| NWC/Revenue: 59.90% < 20% (prev 72.78%; Δ -12.88% < -1%) |
| CFO/TA 0.21 > 3% & CFO 7.15b > Net Income 5.00b |
| Net Debt (10.82b) to EBITDA (8.25b): 1.31 < 3 |
| Current Ratio: 4.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (913.0m) vs 12m ago -0.65% < -2% |
| Gross Margin: 57.02% > 18% (prev 0.58%; Δ 5644 % > 0.5%) |
| Asset Turnover: 50.45% > 50% (prev 44.05%; Δ 6.40% > 0%) |
| Interest Coverage Ratio: 11.52 > 6 (EBITDA TTM 8.25b / Interest Expense TTM 543.0m) |
Altman Z'' 10.00
| A: 0.31 (Total Current Assets 13.75b - Total Current Liabilities 3.16b) / Total Assets 34.59b |
| B: 1.51 (Retained Earnings 52.24b / Total Assets 34.59b) |
| C: 0.18 (EBIT TTM 6.25b / Avg Total Assets 35.05b) |
| D: 2.94 (Book Value of Equity 53.89b / Total Liabilities 18.31b) |
| Altman-Z'' Score: 11.22 = AAA |
Beneish M -3.00
| DSRI: 1.01 (Receivables 1.96b/1.72b, Revenue 17.68b/15.64b) |
| GMI: 1.02 (GM 57.02% / 58.14%) |
| AQI: 0.96 (AQ_t 0.25 / AQ_t-1 0.26) |
| SGI: 1.13 (Revenue 17.68b / 15.64b) |
| TATA: -0.06 (NI 5.00b - CFO 7.15b) / TA 34.59b) |
| Beneish M-Score: -3.00 (Cap -4..+1) = A |
What is the price of TXN shares?
Over the past week, the price has changed by +2.73%, over one month by +16.03%, over three months by +38.11% and over the past year by +24.64%.
Is TXN a buy, sell or hold?
- StrongBuy: 10
- Buy: 2
- Hold: 21
- Sell: 2
- StrongSell: 2
What are the forecasts/targets for the TXN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 215.1 | -2.9% |
| Analysts Target Price | 215.1 | -2.9% |
| ValueRay Target Price | 238.1 | 7.5% |
TXN Fundamental Data Overview January 31, 2026
P/E Forward = 32.2581
P/S = 11.0764
P/B = 12.2046
P/EG = 1.6436
Revenue TTM = 17.68b USD
EBIT TTM = 6.25b USD
EBITDA TTM = 8.25b USD
Long Term Debt = 13.55b USD (from longTermDebt, two quarters ago)
Short Term Debt = 500.0m USD (from shortTermDebt, last quarter)
Debt = 14.05b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.82b USD (from netDebt column, last quarter)
Enterprise Value = 205.02b USD (195.85b + Debt 14.05b - CCE 4.88b)
Interest Coverage Ratio = 11.52 (Ebit TTM 6.25b / Interest Expense TTM 543.0m)
EV/FCF = 78.76x (Enterprise Value 205.02b / FCF TTM 2.60b)
FCF Yield = 1.27% (FCF TTM 2.60b / Enterprise Value 205.02b)
FCF Margin = 14.72% (FCF TTM 2.60b / Revenue TTM 17.68b)
Net Margin = 28.28% (Net Income TTM 5.00b / Revenue TTM 17.68b)
Gross Margin = 57.02% ((Revenue TTM 17.68b - Cost of Revenue TTM 7.60b) / Revenue TTM)
Gross Margin QoQ = 55.89% (prev 57.42%)
Tobins Q-Ratio = 5.93 (Enterprise Value 205.02b / Total Assets 34.59b)
Interest Expense / Debt = 1.00% (Interest Expense 141.0m / Debt 14.05b)
Taxrate = 15.23% (209.0m / 1.37b)
NOPAT = 5.30b (EBIT 6.25b * (1 - 15.23%))
Current Ratio = 4.35 (Total Current Assets 13.75b / Total Current Liabilities 3.16b)
Debt / Equity = 0.86 (Debt 14.05b / totalStockholderEquity, last quarter 16.27b)
Debt / EBITDA = 1.31 (Net Debt 10.82b / EBITDA 8.25b)
Debt / FCF = 4.16 (Net Debt 10.82b / FCF TTM 2.60b)
Total Stockholder Equity = 16.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.27% (Net Income 5.00b / Total Assets 34.59b)
RoE = 30.44% (Net Income TTM 5.00b / Total Stockholder Equity 16.43b)
RoCE = 20.86% (EBIT 6.25b / Capital Employed (Equity 16.43b + L.T.Debt 13.55b))
RoIC = 17.60% (NOPAT 5.30b / Invested Capital 30.12b)
WACC = 10.07% (E(195.85b)/V(209.90b) * Re(10.73%) + D(14.05b)/V(209.90b) * Rd(1.00%) * (1-Tc(0.15)))
Discount Rate = 10.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.11%
[DCF Debug] Terminal Value 66.97% ; FCFF base≈2.16b ; Y1≈1.78b ; Y5≈1.27b
Fair Price DCF = 6.68 (EV 16.88b - Net Debt 10.82b = Equity 6.06b / Shares 907.0m; r=10.07% [WACC]; 5y FCF grow -21.37% → 2.90% )
EPS Correlation: -76.66 | EPS CAGR: -15.80% | SUE: -0.62 | # QB: 0
Revenue Correlation: -50.65 | Revenue CAGR: -2.72% | SUE: -0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.37 | Chg30d=+0.098 | Revisions Net=+1 | Analysts=27
EPS current Year (2026-12-31): EPS=6.42 | Chg30d=+0.295 | Revisions Net=+2 | Growth EPS=+17.8% | Growth Revenue=+10.4%
EPS next Year (2027-12-31): EPS=7.68 | Chg30d=+0.227 | Revisions Net=+1 | Growth EPS=+19.6% | Growth Revenue=+10.0%